Skip to main content
PMC home page
Sexually Transmitted Infections logoLink to Sexually Transmitted Infections
. 2003 Feb;79(1):e1. doi: 10.1136/sti.79.1.e1

Prevalence of and risk factors for hepatitis C virus infection among STD clinic clientele in Miami, Florida

J Weisbord, M Trepka, G Zhang, I Smith, T Brewer
PMCID: PMC1744588  PMID: 12576631

Abstract

Objectives: Hepatitis C virus (HCV) is the most common chronic blood borne viral infection in the United States. We assessed the HCV prevalence, risk factors, and sensitivity of the Centers for Disease Control and Prevention's (CDC) routine screening criteria among clients of a large urban sexually transmitted disease (STD) clinic.

Methods: Participants were recruited from a public STD clinic in Miami, Florida, and were interviewed regarding known and potential risk factors. The survey assessed CDC screening criteria, as well as other risk factors (for example, intranasal drug use, history of incarceration, exchanging sex for money, number of lifetime sex partners, and history of an STD). Testing was done by enzyme immunoassay (EIA) and confirmed by recombinant immunoblot assay (RIBA).

Results: The prevalence of anti-HCV positivity was 4.7%. Four variables were significantly associated with being anti-HCV positive, independent of confounding factors. These included injection drug use (odds ratio (OR) = 31.6; 95% confidence intervals (CI) 11.0 to 90.5); history of incarceration (OR = 3.0; 95% CI 1.1 to 8.1); sexual contact with an HCV positive person (OR 12.7; 95% CI 2.5 to 64.7); and older age (OR 1.4; 95% CI 1.2, 1.6). The sensitivity of CDC's routine screening criteria was 69% and specificity was 91%.

Conclusions: The prevalence of anti-HCV in this clinic was similar to that determined in studies of comparable populations. Having sexual contact with an HCV positive person and history of incarceration were independently associated with being anti-HCV positive. CDC's screening criteria identified approximately two thirds of the anti-HCV positive participants.

Full Text

The Full Text of this article is available as a PDF (112.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akahane Y., Kojima M., Sugai Y., Sakamoto M., Miyazaki Y., Tanaka T., Tsuda F., Mishiro S., Okamoto H., Miyakawa Y. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med. 1994 May 1;120(9):748–752. doi: 10.7326/0003-4819-120-9-199405010-00005. [DOI] [PubMed] [Google Scholar]
  2. Alter M. J., Hadler S. C., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Moyer L. A., Fields H. A., Bradley D. W. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA. 1990 Nov 7;264(17):2231–2235. [PubMed] [Google Scholar]
  3. Añn C., del Olmo J. A., Llovet F., Serra M. A., Gilabert S., Rodríguez F., Rodrigo J. M. Virus C de la hepatitis entre la población penitenciaria de Valencia. Rev Esp Enferm Dig. 1995 Jul;87(7):505–508. [PubMed] [Google Scholar]
  4. Butler T. G., Dolan K. A., Ferson M. J., McGuinness L. M., Brown P. R., Robertson P. W. Hepatitis B and C in New South Wales prisons: prevalence and risk factors. Med J Aust. 1997 Feb 3;166(3):127–130. doi: 10.5694/j.1326-5377.1997.tb140041.x. [DOI] [PubMed] [Google Scholar]
  5. Conry-Cantilena C., VanRaden M., Gibble J., Melpolder J., Shakil A. O., Viladomiu L., Cheung L., DiBisceglie A., Hoofnagle J., Shih J. W. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med. 1996 Jun 27;334(26):1691–1696. doi: 10.1056/NEJM199606273342602. [DOI] [PubMed] [Google Scholar]
  6. Diaz T., Des Jarlais D. C., Vlahov D., Perlis T. E., Edwards V., Friedman S. R., Rockwell R., Hoover D., Williams I. T., Monterroso E. R. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health. 2001 Jan;91(1):23–30. doi: 10.2105/ajph.91.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fiscus S. A., Kelly W. F., Battigelli D. A., Weber D. J., Schoenbach V. J., Landis S. E., Wilber J. C., Van der Horst C. M. Hepatitis C virus seroprevalence in clients of sexually transmitted disease clinics in North Carolina. Sex Transm Dis. 1994 May-Jun;21(3):155–160. doi: 10.1097/00007435-199405000-00005. [DOI] [PubMed] [Google Scholar]
  8. Gunn R. A., Murray P. J., Ackers M. L., Hardison W. G., Margolis H. S. Screening for chronic hepatitis B and C virus infections in an urban sexually transmitted disease clinic: rationale for integrating services. Sex Transm Dis. 2001 Mar;28(3):166–170. doi: 10.1097/00007435-200103000-00008. [DOI] [PubMed] [Google Scholar]
  9. Haber P. S., Parsons S. J., Harper S. E., White P. A., Rawlinson W. D., Lloyd A. R. Transmission of hepatitis C within Australian prisons. Med J Aust. 1999 Jul 5;171(1):31–33. doi: 10.5694/j.1326-5377.1999.tb123494.x. [DOI] [PubMed] [Google Scholar]
  10. Hedouin V., Gosset D. Infection par le virus de l'hépatite C en milieu carcéral. Etude prospective réalisée à Loos-lez-Lille. Gastroenterol Clin Biol. 1998 Jan;22(1):55–58. [PubMed] [Google Scholar]
  11. Hershow R. C., Kalish L. A., Sha B., Till M., Cohen M. Hepatitis C virus infection in Chicago women with or at risk for HIV infection: evidence for sexual transmission. Sex Transm Dis. 1998 Nov;25(10):527–532. doi: 10.1097/00007435-199811000-00006. [DOI] [PubMed] [Google Scholar]
  12. Mele A., Corona R., Tosti M. E., Palumbo F., Moiraghi A., Novaco F., Galanti C., Bernacchia R., Ferraro P. Beauty treatments and risk of parenterally transmitted hepatitis: results from the hepatitis surveillance system in Italy. Scand J Infect Dis. 1995;27(5):441–444. doi: 10.3109/00365549509047042. [DOI] [PubMed] [Google Scholar]
  13. Nakashima K., Kashiwagi S., Hayashi J., Noguchi A., Hirata M., Kajiyama W., Urabe K., Minami K., Maeda Y. Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am J Epidemiol. 1992 Nov 1;136(9):1132–1137. doi: 10.1093/oxfordjournals.aje.a116579. [DOI] [PubMed] [Google Scholar]
  14. Serfaty L. Modes de transmission non transfusionnelle et non par toxicomanie intra-veineuse du VHC. Presse Med. 1999 Jun 12;28(21):1135–1140. [PubMed] [Google Scholar]
  15. Sun D. X., Zhang F. G., Geng Y. Q., Xi D. S. Hepatitis C transmission by cosmetic tattooing in women. Lancet. 1996 Feb 24;347(9000):541–541. doi: 10.1016/s0140-6736(96)91172-1. [DOI] [PubMed] [Google Scholar]
  16. Thomas D. L., Cannon R. O., Shapiro C. N., Hook E. W., 3rd, Alter M. J., Quinn T. C. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis. 1994 May;169(5):990–995. doi: 10.1093/infdis/169.5.990. [DOI] [PubMed] [Google Scholar]
  17. Thomas D. L., Zenilman J. M., Alter H. J., Shih J. W., Galai N., Carella A. V., Quinn T. C. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore--an analysis of 309 sex partnerships. J Infect Dis. 1995 Apr;171(4):768–775. doi: 10.1093/infdis/171.4.768. [DOI] [PubMed] [Google Scholar]
  18. Weinstock H. S., Bolan G., Reingold A. L., Polish L. B. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA. 1993 Jan 20;269(3):392–394. [PubMed] [Google Scholar]
  19. Wejstål R. Sexual transmission of hepatitis C virus. J Hepatol. 1999;31 (Suppl 1):92–95. doi: 10.1016/s0168-8278(99)80382-1. [DOI] [PubMed] [Google Scholar]

Articles from Sexually Transmitted Infections are provided here courtesy of BMJ Publishing Group

RESOURCES